| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Dec 4, 2025 | Replimune Group, Inc. | CEO | Sell | 41.3 | -10,000 | -2.91% | ✓ | $111.3K |
| May 20, 2025 | May 22, 2025 | Replimune Group, Inc. | CEO | Sell | 42.5 | -25,105 | -6.81% | ✗ | $202.3K |
| Dec 16, 2024 | Dec 18, 2024 | Replimune Group, Inc. | CEO | Sell | 37.5 | -10,000 | -4.72% | ✓ | $124.2K |
| Oct 31, 2024 | Nov 4, 2024 | Revolution Medicines, Inc. | Director | Sell | 12.5 | -5,000 | -20.04% | ✓ | $270.7K |
| Jul 9, 2024 | Jul 10, 2024 | Revolution Medicines, Inc. | Director | Sell | 28.8 | -2,155 | -9.75% | ✓ | $94.8K |
| May 16, 2024 | May 20, 2024 | Replimune Group, Inc. | CEO | Sell | 42.5 | -20,194 | -8.70% | ✗ | $130.7K |
| Apr 10, 2024 | Apr 12, 2024 | Revolution Medicines, Inc. | Director | Sell | 25.0 | -2,155 | -12.07% | ✓ | $79.7K |
| Jun 13, 2023 | Jun 15, 2023 | Replimune Group, Inc. | Chief Strategy Officer | Sell | 37.5 | -5,698 | -3.69% | ✓ | $137K |
| May 16, 2023 | May 18, 2023 | Replimune Group, Inc. | Chief Strategy Officer | Sell | 40.0 | -15,575 | -9.15% | ✗ | $281.1K |
| May 16, 2022 | May 18, 2022 | Replimune Group, Inc. | Chief Commercial Officer | Sell | 42.5 | -10,687 | -7.59% | ✗ | $155.9K |